CardioGenesis PMR Not Approvable; Firm May Seek Strategic Investor/Partner
This article was originally published in The Gray Sheet
Executive Summary
CardioGenesis may look for a strategic partner to support its continued pursuit of approval for laser percutaneous myocardial revascularization (PMR)